- Home
- PNTG vs PHVS Comparison
PNTG vs PHVS Comparison
Compare PNTG & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNTG
- PHVS
- Stock Information
- Founded
- PNTG 2019
- PHVS 2015
- Country
- PNTG United States
- PHVS Netherlands
- Employees
- PNTG N/A
- PHVS N/A
- Industry
- PNTG Medical/Nursing Services
- PHVS Biotechnology: Pharmaceutical Preparations
- Sector
- PNTG Health Care
- PHVS Health Care
- Exchange
- PNTG Nasdaq
- PHVS Nasdaq
- Market Cap
- PNTG 1.1B
- PHVS 1.0B
- IPO Year
- PNTG N/A
- PHVS 2021
- Fundamental
- Price
- PNTG $31.43
- PHVS $20.35
- Analyst Decision
- PNTG Buy
- PHVS Buy
- Analyst Count
- PNTG 4
- PHVS 6
- Target Price
- PNTG $38.25
- PHVS $35.67
- AVG Volume (30 Days)
- PNTG 243.3K
- PHVS 80.9K
- Earning Date
- PNTG 11-06-2024
- PHVS 11-13-2024
- Dividend Yield
- PNTG N/A
- PHVS N/A
- EPS Growth
- PNTG 62.21
- PHVS N/A
- EPS
- PNTG 0.68
- PHVS N/A
- Revenue
- PNTG $652,302,000.00
- PHVS N/A
- Revenue This Year
- PNTG $28.68
- PHVS N/A
- Revenue Next Year
- PNTG $17.25
- PHVS N/A
- P/E Ratio
- PNTG $46.18
- PHVS N/A
- Revenue Growth
- PNTG 24.58
- PHVS N/A
- 52 Week Low
- PNTG $12.67
- PHVS $15.00
- 52 Week High
- PNTG $37.13
- PHVS $33.00
- Technical
- Relative Strength Index (RSI)
- PNTG 41.32
- PHVS 43.75
- Support Level
- PNTG $28.80
- PHVS $19.78
- Resistance Level
- PNTG $34.27
- PHVS $25.40
- Average True Range (ATR)
- PNTG 1.39
- PHVS 1.45
- MACD
- PNTG -0.11
- PHVS -0.53
- Stochastic Oscillator
- PNTG 47.30
- PHVS 9.97
About PNTG The Pennant Group Inc.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.
About PHVS Pharvaris N.V.
Pharvaris NV is a clinical-stage company. It is focused on the discovery and development and commercialization of therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases. The company's activities are considered to be one segment which comprises the discovery, development and commercialization of oral bradykinin-B2-receptor antagonists .